CE PRN® Pharmacy Continuing Education Courses 2020

CE PRN® Pharmacy Continuing Education Courses 2020

Pharmacy Liability for Dispensing Errors

0798-0000-19-276-H03-P (for Pharmacists): 0798-0000-19-276-H03-T (for Technicians) June (1.0 Contact Hours)

This monograph discusses the legal responsibility of pharmacists for errors in their product distribution role. The liability exposure of pharmacists for order processing error is examined. The legal case study method is used to demonstrate how pharmacists may be held liable for dispensing errors and how pharmacists may successfully defend themselves in cases alleging liability for dispensing errors.

Buy
CE PRN® Pharmacy Continuing Education Courses 2020

Herbal Use in Cancer Patients… More Common and Concerning Than You May Think

0798-0000-19-105-H01-P (for Pharmacists): 0798-0000-19-105-H01-T (for Technicians) May (1.0 Contact Hours)

A thorough medication review is essential in patients receiving cancer therapy. An important element to discuss is the use of herbal medications with cancer patients. Patients may use herbal supplements for a variety of reasons; to treat their cancer, mitigate side effects, and appease a friend or family member. This program will discuss the use of herbal supplements in cancer patients, and review some of the more common agents used focusing on potential herbal-disease and herbal-drug interactions and concerns.

Buy
CE PRN® Pharmacy Continuing Education Courses 2020, Uncategorized

Whole Patient Care & Diabetes: Recent Updates and Practice Changes

0798-0000-19-067-H01-P (for Pharmacists): 0798-0000-19-067-H01-T (for Technicians) April (2.0 Contact Hours)

Pharmacotherapy for diabetes is a rapidly evolving field. With new agents coming to market and emerging results of cardiovascular trials, medication selection has become increasingly complex. Accordingly, providers rely on pharmacists as medication experts to guide patient-centered decision making.

Buy
CE PRN® Pharmacy Continuing Education Courses 2020

Managing Psoriasis

0798-9999-18-248-H01-P (for Pharmacists) March (1.5 contact hours)

Psoriasis is the most common autoimmune condition in the US, affecting 7.5 million people. It is a complex, genetically linked disease; 1 in every 3 patients with psoriasis has a relative with the condition. The human and economic tolls are signifi­cant. Patients with psoriasis have lower quality of life scores, along with increased occurrences of depression, anxiety and suicidal ideation. In the US, more than $63 million is spent an­nually in direct healthcare costs for psoriasis.

Currently, there is no cure; however, a variety of treat­ments (topical, systemic, phototherapy) are available to manage symptoms, minimize disease progression, and improve quality of life. Since the early 2000s, research into the immunopatho­genesis of psoriasis has led to the development of biologic agents that target specific components of the immune system. Despite the availability of multiple treatments, patients with psoriasis in the US are often under treated, or untreated. Untreated or under treated psoriasis leads to disseminated disease and poten­tially, to joint impairment in the form of psoriatic arthritis (PsA), which causes pain and stiffness of affected joints.

While psoriasis treatment guidelines recommend that trained specialty providers prescribe systemic therapies for patients with this disease, community practitioners should have a sufficient knowledge base to monitor treatment. Frequent patient interactions allow community practitioners, including pharmacists and nurse practitioners, to play an important role in psoriasis management. This issue will review basic information about cutaneous psoriasis and summarize various treatments, so practitioners can better manage and educate patients.

Buy
CE PRN® Pharmacy Continuing Education Courses 2020

Identifying Victims of Human Trafficking in the Health Care Setting

0798-0000-17-193-H04-P (for Pharmacists): 0798-0000-17-193-H04-T (for Technicians) March (2.0 contact hours)

Many health care providers in the United States practice with the thought that human trafficking, also referred to as modern day slavery, does not exist here in the United States. Rather, they believe that it is a problem relevant only to far off distant countries. The truth is that this terrible crime is occurring right here in the United States, just as it is in faraway places. In the United States, roughly 88% of victims have had an interaction with a healthcare provider during their captivity. This puts health care professionals in a unique position to interact with victims in a way that, if appropriately identified, can result in liberation for the victim. Identifying persons believed to be a victim of human trafficking requires health care providers to not only recognize the many types of trafficking that can occur, but also be able to recognize the indicators that unlawful human trafficking may be taking place.

Buy
CE PRN® Pharmacy Continuing Education Courses 2020

The Current Landscape of Biosimilars

0798-0000-19-111-H01-P (for Pharmacists) February (2.0 Contact hours)

The first biosimilar, Zarxio, was approved by the Food and Drug Administration (FDA) in 2015. Since then, 18 other biosimilars have been approved in the U.S. however less than half of them are commercially available on the market. The average whole sale prices of these biosimilars are approximately 15% to 60% lower than that of their respective reference products. In spite of the potential cost savings to health plans and patients, the adoption of biosimilars in the U.S. has been slow. It is important for healthcare providers to understand the current landscape of biosimilars, the agents that are available, their indications, and place in therapy.

Buy
CE PRN® Pharmacy Continuing Education Courses 2020, Medication Errors CE

A Mountain of Mistakes: Moving from Unspoken Tragedy to Effective Collaboration -FL APPROVED-

0798-0000-18-113-H05-P (for Pharmacists); 0798-0000-18-113-H05-T (for Technicians) January (2.0 contact hours)

It is said that success sits atop a mountain of mistakes.  Healthcare teams boast unprecedented resources and tools for reduction in medication error.  Despite staggering technological advances, errors continue.  In fact, new opportunities for error have emerged with some of the very tools intended to eliminate systematic errors.  Using established psychological principles, human engineering factors are examined and extrapolated to the unique challenges of the contemporary pharmacy setting.  Recurring problematic areas in pharmacy practice will be extensively examined within the framework of an effective Continuous Quality Improvement (CQI) Plan and appropriate use of the Root Cause Analysis (RCA) method in identifying, reporting, and evaluating sentinel events.  The vitality of intra- and inter-professional communications is emphasized throughout the didactic structure of this presentation.

This course meets the requirement for the Florida Board of Pharmacy Medication Errors credit for pharmacists and pharmacy technicians.

Buy